EU Gets Going On EMA Move To Amsterdam, Insisting The UK Pay €400m Removal Bill
Executive Summary
Legislation drawn up by the European Commission, formally naming Amsterdam as the EMA’s new home, stresses that the UK will have to bear the costs of the agency’s relocation from London.
You may also be interested in...
User Fee Forecast For May: Approvals Could Sprout In Multiple Divisions
Aimovig, Andexxa, Lucemyra, and pegvaliase are among the almost 20 products with upcoming user fee goals at US FDA this month.
Amsterdam ‘Ticks Many Of Our Boxes,’ Says EMA Head After Dutch Win Race To Host Agency
London has lost the European Medicines Agency to Amsterdam after the Dutch capital beat Milan in a voting process that ended in the drawing of lots. The EMA welcomed the choice of city, saying the decision met many of its requirements and would help to keep down staff losses and ensure business continuity, but Italy was hugely disappointed at losing out in what amounted to a toss of a coin.
WHO Launches Twin-Track Procedure To Speed Access To Health Products
A procedure used to accelerate the approval of COVID-19 products during the pandemic is to be applied to all medicines using “synchronized and parallel, but otherwise entirely independent, processes,” the World Health Organization says.